← Eichor
Study identifier: NCT07176416 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Condition: Cataract  ·  Sponsor: Aloha Vision Consultants

PhaseN/A
Planned participants50
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

This description comes directly from the study's public registry record.

Talk to the study team

Alana K Dunn  ·  808-688-6898  ·  avc.alanad@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Aloha Vision Consultants‘Aiea, Hawaii, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07176416